Financial ties that might bind

Delve deeper to find the links

BMJ 2008; 336 doi: 10.1136/bmj.39450.701262.3A (Published 10 January 2008)
Cite this as: BMJ 2008;336:59.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. John H Noble Jr, emeritus professor, State University of New York at Buffalo
  1. 1508 Rio Grande Loop, Georgetown, TX 78633, USA
  1. jhnoble{at}verizon.net

    The finding by Yank et al of no connection between results in meta-analyses and financial ties is surprising,1 given the greater deficiencies for reporting of harm outcomes among trials that were solely funded by industry (median 56% per trial) than among trials that were not (27%).2 Evidently the Oxman-Guyatt measure of scientific quality of research reviews used by Yank et al cannot capture discrepancies in original …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL